Group 1 - The company held its 29th meeting of the 9th Board of Directors on December 26, 2025, where it approved the proposal regarding the progress of external investment in purchasing equity and signing a supplementary agreement [2][3][10] - The board meeting was attended by all 9 directors, and the decision was made unanimously with 9 votes in favor [4][5] - The company announced that the external investment in purchasing equity does not involve related transactions and does not constitute a major asset restructuring as per relevant regulations [9][23] Group 2 - The company is acquiring equity in Shandong Zhongfu Heda New Materials Co., Ltd. to enhance its cellulose ether product line and overall competitiveness [10][24] - The maximum acquisition price has been reduced from 294 million RMB to 191 million RMB due to changes in market conditions, which aligns with the company's investment objectives [14][27] - The target company, Zhongfu Heda, is a leading domestic producer of HEC (hydroxyethyl cellulose) with a production capacity of 10,000 tons per year and strong market competitiveness [25][26] Group 3 - The supplementary agreement adjusts the conditions for the second phase of the acquisition, requiring the target company to maintain profitability until 2027, with a revised maximum share price of 7 RMB [20][22] - The company has completed the first phase of the acquisition, holding 47.0796% of the target company's equity as of September 25, 2023 [11][10] - The target company's products have significant applications in various industries, including oilfield, personal care, and high-end coatings, indicating strong growth potential [26][24]

Core Viewpoint - The company faces significant anti-dumping and countervailing duties from the U.S. Department of Commerce, impacting its exports of hard-shell capsules to the U.S. market, prompting the establishment of a special task force to address the situation [1][3]. Group 1: Anti-Dumping and Countervailing Duties - The preliminary anti-dumping duty rate for the company's subsidiary, Shandong Hershey Capsule Co., Ltd., is set at 172.24%, while other Chinese producers/exporters face rates between 5.4% and 88.82% [1]. - The preliminary countervailing duty rate for Shandong Hershey is 6.82%, with other Chinese producers/exporters facing rates between 3.45% and 8.53% [1]. - The U.S. will require importers to pay these duties as a cash deposit until the final rates are determined after the first annual review, expected to be published in October 2025 [1]. Group 2: Company Response and Strategy - The company is actively preparing for a field investigation by the U.S. Department of Commerce to seek a fair final ruling and has engaged a legal team to challenge the preliminary ruling [3]. - The company has maintained a stock of products in the U.S. that can meet market demand for 5 to 6 months, indicating proactive inventory management [3]. - The company is advancing a project to establish a plant in the U.S. with a capacity of 20 billion capsules per year, which has completed site selection and initial negotiations [3]. Group 3: Business Performance and Future Outlook - In 2024, the company reported revenue of 1.957 billion yuan, a year-on-year increase of 25.72%, with net profit reaching 222 million yuan, up 0.65% [4]. - Overseas revenue for 2024 was 1.232 billion yuan, a 36.19% increase, accounting for 62.96% of total revenue, reflecting deepened international market expansion [4]. - The company plans to achieve revenue of 2.25 billion yuan in 2025, with specific targets for various segments, including 1.69 billion yuan from cellulose ether and 400 million yuan from plant capsules [4].